Biocon Biologics Inc.

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Biocon Biologics Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Biocon Biologics Inc.

Biocon Biologics Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by TRASTUZUMAB-DKST. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: breast cancer, indicated adults, select patients, therapy based, fda-approved companion, trastuzumab product, overexpressing metastatic, see dosage. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
TRASTUZUMAB-DKST 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — INTRAVENOUS 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Biocon Biologics Inc.

Brand nameGenericTypeRoute
OGIVRI TRASTUZUMAB-DKST HUMAN PRESCRIPTION DRUG INTRAVENOUS

Frequently asked questions

How many FDA drug products does Biocon Biologics Inc. make?
1 FDA drug label records name Biocon Biologics Inc. as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Biocon Biologics Inc. produce?
The most frequent active ingredients in this portfolio are TRASTUZUMAB-DKST.

Are Biocon Biologics Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.